University of South Florida Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
- Institution
- WESTAT, INC., MD
- Principal investigator
- Patricia J Emmanuel
- Funding
- $327K
- Duration
- 2022–2029
Moonbase score
Still being scored
Abstract
ABSTRACT University of South Florida The USF Adolescent HIV Consortium will collaborate with the Adolescent Trials Network (ATN) Operations and Collaborations Center (OCC) by engaging, enrolling, and retaining adolescents and young adults, both at risk of and living with HIV, in care and research through a well-established clinical and research infrastructure. This highly reliable, inclusive consortium structure serves southwest Florida and includes community-based programs, youth representatives, local health departments, health systems and academic institutions. The consortium will utilize proven strategies and innovative programs to respond to the needs of youth and the community. Through engagement at the site and individual collaborator level with the ATN Scientific Leadership Group, the consortium will implement and investigate new research strategies that will result in improved prevention and treatment of HIV infection and address pressing issues of youth living with HIV. We will leverage our experience, mature partnerships, and diverse patient population to address priority areas of the ATN agenda and serve as a model for community empowerment and participation.
LOADING MOONBASE SCORE
Questions for Westat, Inc.
Westat, Inc. hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same institution, same topic, scored first.
- NIH · Westat, Inc.Reviewed
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
Marvin E Belzer · $343K · 2022–2029
- NIH · Westat, Inc.Not yet scored
Early Psychosis Intervention Network (EPINET) Data Coordinating Center
Abram Rosenblatt · $2.0M · 2025–2030
- NIH · Westat, Inc.Not yet scored
IMPAACT 2041: PHASE I/II STUDY OF THE PHARMACOKINETICS AND SAFETY OF GLECAPREVIR/PIBRENTASVIR INITIATED IN PREGNANCY IN PEOPLE WITH HEPATITIS C WITH AND WITHOUT HIV
Barbara Driver · $1.1M · 2025–2028